Prostate cancer ranks as the third most common cancer in the United States and the fourth most prevalent globally. It is most often diagnosed in men aged between 65 and 74, with the median age at ...

Prostate cancer describes the development of cancer in the prostate. The prostate is a gland in the male reproductive system. The disease normally develops slowly, with symptoms emerging sometime ...

Summary: Genetic screening enhances effectiveness of immunotherapy in treating prostate cancer, with disease progression slowed by up to 33 months in some patients. Estimated reading time: 5 minutes A ...

In a recent Yale-led clinical trial, a new type of prostate cancer drug showed promising results in reducing tumor activity ...

A University of East Anglia-led analysis recovered 249 near-complete bacterial genomes from prostate cancer sequencing data, ...

Why do some prostate cancers grow slowly for years, while others progress quickly to life-threatening metastatic disease? An ...

UChicago researchers identify a previously unknown RNA molecule that allows prostate cancer cells to escape targeted ...

Prostate cancer is 2nd most commonly occurring cancer in men but also one of the least understood. Here are nine things the experts think every man should know about the fourth leading cause of cancer ...

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...